Bob Kronemyer

Conduct evidence-based pretreatment assessments prior to procedures to identify vulnerable patients. Vulnerable patients are at risk for ill-advised or opportunistic treatment from undereducated aesthetic providers.

For melanoma, patient and physician education is key. Laser treatment for hyperpigmentation in darker skin effective. Teledermatology could replace office visits in this underserved population.

80% of practices will experience embezzlement every five years. To protect yourself, one expert advises: Avoid blind trust; rely on written checks for refunds; separate employee duties; routinely audit financial systems; and consider going cashless.

Nitric oxide-releasing cream that targets IL-17 moving toward clinical trials.

Application of a topical photoparticle immediately before non-ablative 810 nm diode laser treatment for acne resulted in a statistically significant reduction from baseline in inflammatory acne counts on the back, according to a small feasibility study presented in April at ASLMS.

In this slideshow, we feature Dr. Eliot Battle who offers recommendations for laser treatment in non-white patients. Lasers are as diverse as the patients and conditions they are designed to treat, he says.

A pilot study has successfully challenged the current non-evidenced medical recommendation that patients with acne scars should wait six to 12 months after completion of oral isotretinoin treatment before the safe initiation of nonablative fractional laser resurfacing.

A nitric oxide-releasing gel to treat acne vulgaris has been found to be extremely safe, according to three Phase 1 pharmacokinetic clinical trials.

A nitric oxide-releasing cream to treat psoriasis and atopic dermatitis is in development.

Adalimumab (Humira, AbbVie) enhances both health-related quality of life and work productivity in patients with moderate-to-severe hidradenitis suppurativa, according to the results of two phase 3 clinical trials.

There are both unique nuances and cultural considerations to rejuvenating the skin of East Asian patients, according to one dermatologist.

The goal of a tiered approach to acne is to improve both the patient’s acne and quality of life, while promoting responsible use of antibiotics.

Many dermatologists use spironolactone as a treatment in conjunction with traditional therapies, birth control and other hormonal modalities to help with the hormonal component of acne in adult women.

The clinical presentation of acne vulgaris in darker-skinned individuals differs in many ways from the white population, including some specific exacerbating factors that are due to cultural skin and hair-care practices.

The tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.

When it comes to treating atopic dermatitis in non-white racial ethnic groups, there are variations in prevalence, genetic factors and clinical presentation.

Atopic dermatitis normalizes the skin micro biome. Anti-inflammatory medications for atopic dermatitis reduce colonization. Children with atopic dermatitis more prone to molluscum infection.

The difference between acne and healthy skin is largely dependent on the balance of the skin microbiota, according to study results.

There is a shift in skin aging by decades, depending on ethnicity, according to results of a scientific evaluation underwritten by Proctor & Gamble Co.

A silicone-based gel with a nitric oxide platform has been found to be safe and efficacious for treating tinea pedis, according to the results of a Phase 2 trial.

Application of a topical photoparticle immediately before non-ablative 810 nm diode laser treatment for acne resulted in a statistically significant reduction from baseline in inflammatory acne counts on the back, according to a small feasibility study.

A new study finds that use of dual laser therapy alone in skin types V and VI achieves excellent results with an exceptional side-effect profile.

Laser for melanoma in situ (MIS) should generally be reserved for nonsurgical, usually elderly patients. When indicated, MIS may be treated with CO2 laser or with combined Q-switched Nd:YAG and imiquimod. Any atypical-appearing lesion should be biopsied prior to the start of a laser treatment.

All surgical management of melanoma is defined by Breslow thickness. For melanoma less than 1 mm in thickness, typically a SLNB is not required. Future imaging devices may better delineate the extent and depth of the tumor in vivo.

Genetic profiling is valuable in both diagnosis and prognosis of skin cancer. Hedgehog inhibitors and (superficial radiation therapy) SRT are strong contenders for treating nonmelanoma skin cancer. Advances in targeted therapies and biologics are part of the new wave of melanoma treatments.

Hormonal therapies are an effective strategy to improve acne in women but some of these treatments, including birth control pills, are not commonly prescribed.

As part of its updated guidelines for the treatment of acne published early last year, the American Academy of Dermatology included new recommendations for the use of oral isotretinoin.

Instructional handouts help caregivers stick to complicated treatment plans for pediatric AD patients. Historically effective AD treatments are being augmented with new phosphodiesterase inhibitors and biologics. Gentler approaches such as massage, light therapy, and melatonin may also be of value for children with AD.

Drugs to treat atopic dermatitis are at the top of the FDA’s dermatology list. Biologics and PDE4 inhibitors show promise in the treatment of AD. Approval is still needed for the use of biologics to treat AD in pediatric patients.

Cyclosporine and PUVA clearly increase the risk of squamous cell carcinomas, and there is evidence that TNF blockers and methotrexate may do so to a lesser degree. UVB phototherapy has not been shown to cause skin cancer. Acitretin offers protection against the development of basal cell and squamous cell carcinomas.